We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$12.1B
AUM Growth
+$1.27B
Cap. Flow
+$1.03B
Cap. Flow %
8.56%
Top 10 Hldgs %
10.66%
Holding
624
New
180
Increased
169
Reduced
84
Closed
163

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$135M
2
NXPI icon
NXP Semiconductors
NXPI
+$129M
3
FANG icon
Diamondback Energy
FANG
+$103M
4
TXN icon
Texas Instruments
TXN
+$98.4M
5
CRM icon
Salesforce
CRM
+$96.2M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$217M
2
PANW icon
Palo Alto Networks
PANW
+$120M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$120M
4
LNKD
LinkedIn Corporation
LNKD
+$110M
5
MRK icon
Merck
MRK
+$100M

Sector Composition

Rank Sector Weight
1 Technology 15.27%
2 Industrials 13.28%
3 Healthcare 12.87%
4 Consumer Discretionary 10.6%
5 Consumer Staples 10.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GEVO icon
451
CALL
Gevo
GEVO
$382M
$336K ﹤0.01%
243
– –
RLJE
452
CALL
DELISTED
RLJ Entertainment, Inc.
RLJE
$320K ﹤0.01%
200,000
– –
VAC icon
453
Marriott Vacations Worldwide
VAC
$4.25B
$268K ﹤0.01%
+3,156
New +$238K
EACQ
454
CALL
DELISTED
Easterly Acquisition Corp
EACQ
$267K ﹤0.01%
761,707
– –
SVRA icon
455
CALL
Savara
SVRA
$1.19B
$258K ﹤0.01%
42,420
– –
WINT
456
CALL
DELISTED
Windtree Therapeutics Inc
WINT
$223K ﹤0.01%
178,570
– –
SLS icon
457
CALL
SELLAS Life Sciences
SLS
$2.36B
$154K ﹤0.01%
+53
New +$308K
PARN
458
DELISTED
Parnell Pharmaceuticals Holdings Ltd
PARN
$102K ﹤0.01%
147,458
– –
KALV
459
DELISTED
KalVista Pharmaceuticals
KALV
$81K ﹤0.01%
11,483
-35
-0.3% -$258
BLPH
460
DELISTED
Bellerophon Therapeutics, Inc.
BLPH
$80K ﹤0.01%
10,286
+82
+0.8% +$1.14K
AAPL icon
461
Apple
AAPL
$4.57T
– –
-7,670,460
Closed -$217M
ABT icon
462
Abbott
ABT
$187B
– –
-1,675,854
Closed -$70.9M
ACIU icon
463
AC Immune
ACIU
$240M
– –
-85,000
Closed -$1.4M
ADTN icon
464
Adtran
ADTN
$616M
– –
-530,638
Closed -$10.2M
AJG icon
465
Arthur J. Gallagher & Co
AJG
$63.6B
– –
-62,829
Closed -$3.2M
ALB icon
466
Albemarle
ALB
$15.5B
– –
-340,000
Closed -$29.1M
ALLE icon
467
Allegion
ALLE
$14.4B
– –
-51,237
Closed -$3.53M
AMG icon
468
Affiliated Managers Group
AMG
$9.76B
– –
-71,173
Closed -$10.3M
AOS icon
469
A.O. Smith
AOS
$8.7B
– –
-82,082
Closed -$4.05M
APD icon
470
Air Products & Chemicals
APD
$67.6B
– –
-162,844
Closed -$22.6M
APH icon
471
Amphenol
APH
$209B
– –
-2,177,636
Closed -$35.3M
AVY icon
472
Avery Dennison
AVY
$13.4B
– –
-120,699
Closed -$9.39M
AX icon
473
Axos Financial
AX
$5.68B
– –
-309,153
Closed -$6.92M
BABA icon
474
Alibaba
BABA
$308B
– –
-100,000
Closed -$10.6M
BALL icon
475
Ball Corp
BALL
$16.8B
– –
-482,148
Closed -$19.8M
17 18
19
20 21

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q4 2016 Portfolio in Review

As of Q4 2016, Alyeska Investment Group held 624 positions worth $12.1B, up 12% from $10.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Alyeska Investment Group deployed $1.03B of net new capital in Q4 2016, opening 180 new positions and adding to 169 existing holdings. Its largest new stake was Texas Instruments: 1,378,860 shares worth $101M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Palo Alto Networks, an estimated $120M trimmed.

  • Alyeska Investment Group's largest Q4 2016 buy was Texas Instruments: 1,378,860 shares worth $101M.
  • Alyeska Investment Group added most to Alphabet (Google) Class A in Q4 2016, an estimated $135M increase.
  • Alyeska Investment Group's biggest Q4 2016 reduction was Palo Alto Networks, cutting an estimated $120M.
  • Alyeska Investment Group fully exited Apple in Q4 2016, selling an estimated $217M.
  • Alyeska Investment Group's ten largest holdings make up 11% of its $12.1B portfolio in Q4 2016.
  • Alyeska Investment Group opened 180 new positions and closed 163 in Q4 2016.
  • Alyeska Investment Group's portfolio value rose 12% quarter-over-quarter to $12.1B.

Based on Alyeska Investment Group's 13F filing for Q4 2016, filed 14 Feb 2017.